Mometamax Single™ Otic Suspension for Dogs

24 ml (20 Doses/0.8 ml each)

INTERVET INC dba MERCK
Manufacturer Item #:228979
Patterson Item #:07-895-3771
Package Quantity: 24 ml (20 Doses/0.8 ml each) Active Ingredient: Gentamicin, Posaconazole, Mometasone futoate Volume: 24 ml (20 doses) Presentation: Otic Suspension
See My Price
Quantity
Choose a comparable product or call 1-800-225-7911 for assistance
Overview
Product Specifications

Mometamax Single™ (gentamicin, posaconazole, and mometasone furoate otic suspension) Otic Suspension for Dogs is a single-dose, in-clinic treatment for otitis externa caused by yeast and bacteria. This convenient solution is administered by a veterinarian and treats infections caused by Malassezia pachydermatis, Staphylococcus pseudintermedius, and Pseudomonas aeruginosa. With its triple-action formula, it delivers long-lasting relief with no need for at-home follow-up. Not for use in cats.

  • In-clinic treatment—administered by a veterinarian
  • Treats yeast and bacterial infections, including Pseudomonas aeruginosa
  • Triple-action formula: antibacterial, antifungal, and anti-inflammatory
  • Provides more than 4 weeks of efficacy
  • No refrigeration required

Package Quantity: 24 ml (20 Doses/0.8 ml each) Active Ingredient: Gentamicin, Posaconazole, Mometasone futoate Volume: 24 ml (20 doses) Presentation: Otic Suspension NDC Number: 00061-5432-01 Contains: One bottle of Mometamax Single containing 24 ml (20 doses), one plastic-wrapped dosing syringe with attached adapter, and 19 additional dosing syringes. Container Type: Plastic Bottle Delivery Type: Topical Doses Per Unit: 20 For Animal Type: Dog NDC Number: 00061-5432-01

05/05/2025 - 07/31/2025
Valid May 5, 2025 - July 31, 2025. *Vets* Buy 3 packs of Mometamax Single, Get 1 pack of Mometamax 12x15g FREE! *Free item: 78946833 MOMETAMAX OTIC SUSPENSION (RX) 12X15GM *Must pay vet retail price *Buying Groups/Corporate Accounts eligible *Must be invoiced within 10 daysof the promotion end date

Promotions Expiration: 07/31/2025